Breast Cancer News and Research

Latest Breast Cancer News and Research

Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy

Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy to reduce the risk of cancer in the opposite breast, according to the first large-scale study evaluating the impact of genetic counseling and testing on breast cancer treatment decisions.

5 Apr 2004

BRITONS risk dying prematurely from cancer due to ignorance

An NOP survey, released today by Cancer Research UK's Race for Life, reveals that only three per cent of those surveyed know that people who are overweight are more likely to develop cancer than people of normal weight, while 70 per cent are aware of the link with heart disease.

5 Apr 2004

First patient dosed with Tesmilifene in pivotal breast cancer study

YM BioSciences Inc., the cancer drug development company, today announced that the first patient has been dosed in its 700 patient Phase III registration trial.

31 Mar 2004

No increased risk of breast cancer from miscarriage or abortion

An international collaboration led by Oxford University concluded in last week's issue of The Lancet that there is no increased risk of breast cancer for women who have had a pregnancy ending in miscarriage or abortion.

30 Mar 2004

Enzyme called COX-2 may promote the development of ovarian tumors

Fox Chase Cancer Center scientists have identified how an enzyme called COX-2 may promote the development of ovarian tumors, adding further insight into the mechanism of COX-2 inhibitors and the prevention of this highly lethal disease. The data was presented today at the 95th Annual Meeting of the American Association for Cancer Research in Orlando, Fla.

29 Mar 2004

Researchers tap modified plant viruses to ward off cervical cancer-causing infections

New vaccinations to prevent infections that lead to cervical cancer and targeted therapeutics aimed at breast cancer were examples of research highlights presented by scientists today at the 95th Annual Meeting of the American Association for Cancer Research. Scientists described advances that feed into the drug development 'pipeline,' and show strong promise for controlling existing tumors or addressing the pathogen that causes tumors.

29 Mar 2004

Colorectal cancer and preventative screening legislation in the US

Even though colorectal cancer is one of the most preventable types of cancer, only 18 US states have enacted legislation requiring insurance providers to cover the cost of preventative screening. These findings from the 2004 Colorectal Cancer Legislation Report Card were released today by the Entertainment Industry Foundation’s National Colorectal Cancer Research Alliance (EIF’s NCCRA) and the American Gastroenterological Association (AGA).

29 Mar 2004

Renowned researchers, scientists share advances in prevention, diagnosis, therapy

Leading researchers are gathering today for the 95th Annual Meeting of the American Association for Cancer Research (AACR), the premier multidisciplinary assembly, which features the latest developments in basic, prevention, translational and clinical cancer research. The meeting occurs from March 27 – 31, 2004 at the Orlando Convention Center, Fla.

27 Mar 2004

Researchers have successfully grafted human breast tissue into the mammary glands of mice

The last few years have witnessed critical advances in breast cancer therapies. Still, the disease afflicts one in eight American women, and scientists have yet to develop a living model with which they can study the intricacies of human breast-tumor behavior.

26 Mar 2004

Pregnancies that end in miscarriage or abortion do not increase a woman's risk of developing breast cancer

A Study coordinated by Cancer Research UK scientists has shown that pregnancies that end in miscarriage or abortion do not increase a woman's risk of developing breast cancer later in life.

26 Mar 2004

iCAD issued with Fulcrum mammography film digitizer patent

iCAD, Inc., which designs, develops and markets Computer Aided Detection (CAD) imaging technology and systems for the early detection of breast cancer and other medical applications, today announced that the U.S. Patent and Trademark Office has issued the Company two patents for its Fulcrum mammography film digitizer and technology.

24 Mar 2004

New computer program accurately estimates chance of developing breast cancer

CANCER Research UK scientists have devised a user-friendly computer program, called the IBIS risk evaluator, which can give the most accurate estimate yet of a woman's chance of developing breast cancer.

22 Mar 2004

Pfizer breast cancer drug looks to be best in field

A breast cancer drug made by Pfizer Inc. increased survival rates by 63 percent compared with the standard therapy tamoxifen, researchers said on Wednesday. The clinical trial strengthens the case for administering the newer drug, exemestane, as a first option. A study published last week showed that women recovering from breast cancer lowered their chance of developing another tumor by 32 percent if they switched to exemestane after two or three years of tamoxifen treatment.

22 Mar 2004

Pharmexa vaccine is designed to induce antibody responses against the HER-2 protein

Pharmexa presents data from the HER-2 Protein AutoVac™ breast cancer trial at a Conference in Hamburg Summary: Pharmexa is presenting data from the first clinical trial in USA with the HER-2 Protein AutoVac™ vaccine at the 4th European Breast Cancer Conference (EBCC) in Hamburg, Germany.

22 Mar 2004

Research suggests the orlistat drug could be used to fight cancer and obesity

The Burnham Institute’s Jeffrey Smith, Ph.D., has discovered that orlistat, commonly prescribed as an anti-obesity drug, has a positive side-effect: it inhibits cancer growth. Dr. Smith made this discovery using an activity-based proteomics screening technique developed in his laboratory that makes it possible to identify active targets and simultaneously screen for their inhibitors.

22 Mar 2004

Improvements needed in breast cancer treatment

Treatment of ductal carcinoma in situ (DCIS), a group of abnormal cells confined to the breast ducts, varies widely in the United States. Treatment ranges from potential over-treatment with aggressive surgical therapy to possible under-treatment by not providing radiation.

22 Mar 2004

Obesity Drug Inhibits Prostate Tumor Growth

The Burnham Institute's Jeffrey Smith, Ph.D. has discovered that orlistat, commonly prescribed as an anti-obesity drug, has a positive side-effect: it inhibits cancer growth. Dr. Smith made this discovery using an activity-based proteomics screening technique developed in his laboratory that makes it possible to identify active targets and simultaneously screen for their inhibitors.

22 Mar 2004

Breast Cancer News and Research

Latest Breast Cancer News and Research

Newly diagnosed breast cancer patients who test positive for BRCA1 and BRCA2 gene mutations are twice as likely as non-carriers to opt for a double mastectomy

BRITONS risk dying prematurely from cancer due to ignorance

First patient dosed with Tesmilifene in pivotal breast cancer study

No increased risk of breast cancer from miscarriage or abortion

Enzyme called COX-2 may promote the development of ovarian tumors

Researchers tap modified plant viruses to ward off cervical cancer-causing infections

Colorectal cancer and preventative screening legislation in the US

Renowned researchers, scientists share advances in prevention, diagnosis, therapy

Researchers have successfully grafted human breast tissue into the mammary glands of mice

Pregnancies that end in miscarriage or abortion do not increase a woman's risk of developing breast cancer

iCAD issued with Fulcrum mammography film digitizer patent

New computer program accurately estimates chance of developing breast cancer

Pfizer breast cancer drug looks to be best in field

Pharmexa vaccine is designed to induce antibody responses against the HER-2 protein

Research suggests the orlistat drug could be used to fight cancer and obesity

Improvements needed in breast cancer treatment

Obesity Drug Inhibits Prostate Tumor Growth

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Breast Cancer News and Research

Latest Breast Cancer News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in